773 related articles for article (PubMed ID: 21723614)
1. Comparative effectiveness and cost-effectiveness of the implantable miniature telescope.
Brown GC; Brown MM; Lieske HB; Lieske PA; Brown KS; Lane SS
Ophthalmology; 2011 Sep; 118(9):1834-43. PubMed ID: 21723614
[TBL] [Abstract][Full Text] [Related]
2. The value-based medicine comparative effectiveness and cost-effectiveness of penetrating keratoplasty for keratoconus.
Roe RH; Lass JH; Brown GC; Brown MM
Cornea; 2008 Oct; 27(9):1001-7. PubMed ID: 18812762
[TBL] [Abstract][Full Text] [Related]
3. A value-based medicine analysis of ranibizumab for the treatment of subfoveal neovascular macular degeneration.
Brown MM; Brown GC; Brown HC; Peet J
Ophthalmology; 2008 Jun; 115(6):1039-1045.e5. PubMed ID: 17976724
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of the Boston keratoprosthesis.
Ament JD; Stryjewski TP; Ciolino JB; Todani A; Chodosh J; Dohlman CH
Am J Ophthalmol; 2010 Feb; 149(2):221-228.e2. PubMed ID: 19939347
[TBL] [Abstract][Full Text] [Related]
5. Cost-utility analysis of cataract surgery in the second eye.
Busbee BG; Brown MM; Brown GC; Sharma S
Ophthalmology; 2003 Dec; 110(12):2310-7. PubMed ID: 14644712
[TBL] [Abstract][Full Text] [Related]
6. The Cost-Effectiveness of Ranibizumab for the Treatment of Diabetic Macular Edema.
Brown GC; Brown MM; Turpcu A; Rajput Y
Ophthalmology; 2015 Jul; 122(7):1416-25. PubMed ID: 25935787
[TBL] [Abstract][Full Text] [Related]
7. A value-based medicine cost-utility analysis of idiopathic epiretinal membrane surgery.
Gupta OP; Brown GC; Brown MM
Am J Ophthalmol; 2008 May; 145(5):923-8. PubMed ID: 18329000
[TBL] [Abstract][Full Text] [Related]
8. Computerized model of cost-utility analysis for treatment of age-related macular degeneration.
Fletcher EC; Lade RJ; Adewoyin T; Chong NV
Ophthalmology; 2008 Dec; 115(12):2192-8. PubMed ID: 18930556
[TBL] [Abstract][Full Text] [Related]
9. [Cost-utility analysis of ranibizumab (Lucentis) in neovascular macular degeneration].
Neubauer AS; Holz FG; Schrader W; Back EI; Kühn T; Hirneiss C; Kampik A
Klin Monbl Augenheilkd; 2007 Sep; 224(9):727-32. PubMed ID: 17846963
[TBL] [Abstract][Full Text] [Related]
10. Global cost-effectiveness of cataract surgery.
Lansingh VC; Carter MJ; Martens M
Ophthalmology; 2007 Sep; 114(9):1670-8. PubMed ID: 17383730
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
[TBL] [Abstract][Full Text] [Related]
12. Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results.
Hudson HL; Lane SS; Heier JS; Stulting RD; Singerman L; Lichter PR; Sternberg P; Chang DF;
Ophthalmology; 2006 Nov; 113(11):1987-2001. PubMed ID: 16989902
[TBL] [Abstract][Full Text] [Related]
13. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
Haentjens P; De Groote K; Annemans L
Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
[TBL] [Abstract][Full Text] [Related]
14. Cost utility for penetrating keratoplasty in patients with poor binocular vision.
Hirneiss C; Neubauer AS; Niedermeier A; Messmer EM; Ulbig M; Kampik A
Ophthalmology; 2006 Dec; 113(12):2176-80. PubMed ID: 16996598
[TBL] [Abstract][Full Text] [Related]
15. Value-based medicine, comparative effectiveness, and cost-effectiveness analysis of topical cyclosporine for the treatment of dry eye syndrome.
Brown MM; Brown GC; Brown HC; Peet J; Roth Z
Arch Ophthalmol; 2009 Feb; 127(2):146-52. PubMed ID: 19204231
[TBL] [Abstract][Full Text] [Related]
16. Cost-utility analysis of cochlear implants in Korea using different measures of utility.
Lee HY; Park EC; Kim HJ; Choi JY; Kim HN
Acta Otolaryngol; 2006 Aug; 126(8):817-23. PubMed ID: 16846923
[TBL] [Abstract][Full Text] [Related]
17. Cataract surgery cost utility revisited in 2012: a new economic paradigm.
Brown GC; Brown MM; Menezes A; Busbee BG; Lieske HB; Lieske PA
Ophthalmology; 2013 Dec; 120(12):2367-2376. PubMed ID: 24246824
[TBL] [Abstract][Full Text] [Related]
18. Opportunities to Reduce Potential Bias in Ophthalmic Cost-Utility Analysis.
Brown GC; Brown MM; Chaudhry I; Stein JD
JAMA Ophthalmol; 2021 Apr; 139(4):389-397. PubMed ID: 33538789
[TBL] [Abstract][Full Text] [Related]
19. A value-based medicine comparison of interventions for subfoveal neovascular macular degeneration.
Brown GC; Brown MM; Brown HC; Kindermann S; Sharma S
Ophthalmology; 2007 Jun; 114(6):1170-8. PubMed ID: 17320964
[TBL] [Abstract][Full Text] [Related]
20. Economic appraisal of the Boston Ocular Surface Prosthesis.
Shepard DS; Razavi M; Stason WB; Jacobs DS; Suaya JA; Cohen M; Rosenthal P
Am J Ophthalmol; 2009 Dec; 148(6):860-8.e2. PubMed ID: 19781684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
